Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry
Behnood Bikdeli,César Caraballo,Javier Trujillo-Santos,Jean Philippe Galanaud,Pierpaolo di Micco,Vladimir Rosa,Gemma Vidal Cusidó,Sebastian Schellong,Meritxell Mellado,María Del Valle Morales,Olga Gavín-Sebastián,Lucia Mazzolai,Harlan M Krumholz,Manuel Monreal,RIETE Investigators,Paolo Prandoni NA,Benjamin Brenner NA,Dominique Farge-Bancel NA,Raquel Barba NA,Laurent Bertoletti NA,Inna Tzoran NA,Abilio Reis NA,Marijan Bosevski NA,Henri Bounameaux NA,Radovan Malý NA,Peter Verhamme NA,Joseph A Caprini NA,María Dolores Adarraga NA,Paloma Agudo de Blas NA,Jesús Aibar NA,Cristina Amado NA,Juan Ignacio Arcelus NA,Aitor Ballaz NA,Cristina Barbagelata NA,Manuel Barrón NA,Belén Barrón-Andrés NA,Ángeles Blanco-Molina NA,Fahd Beddar Chaib NA,Ernesto Botella NA,Beatriz Buño-Ramilo NA,Joaquín Castro NA,Leyre Chasco NA,Juan Criado NA,Cristina de Ancos NA,Javier de Miguel NA,Jorge Del Toro NA,Pablo Demelo-Rodríguez NA,Ana María Díaz-Brasero NA,María Del Carmen Díaz-Pedroche NA,José Antonio Díaz-Peromingo NA,Raquel Díaz-Simón NA,Irene Milagros Domínguez NA,Álvaro Dubois-Silva NA,José Carlos Escribano NA,Francis Espósito NA,Ana Isabel Farfán-Sedano NA,Carmen Fernández-Capitán NA,José Luis Fernández-Reyes NA,Ángeles Fidalgo NA,Carme Font NA,Iria Francisco NA,Cristina Gabara NA,Francisco Galeano-Valle NA,María Angelina García NA,Ferrán García-Bragado NA,Marta García de Herreros NA,Rocío García de la Garza NA,Covadonga García-Díaz NA,Aída Gil-Díaz NA,Mario Giménez-Suau NA,Covadonga Gómez-Cuervo NA,Enric Grau NA,Leticia Guirado NA,Javier Gutiérrez NA,Luis Hernández-Blasco NA,Luis Jara-Palomares NA,María Jesús Jaras NA,David Jiménez NA,Rafael Jiménez NA,Carmen Jiménez-Alfaro NA,Inés Jou NA,María Dolores Joya NA,Sara Lainez-Justo NA,Antonio Lalueza NA,Ana Latorre-Díez NA,José Luis Lobo NA,Luciano López-Jiménez NA,Patricia López-Miguel NA,Juan José López-Núñez NA,Raquel López-Reyes NA,Juan Bosco López-Sáez NA,Alicia Lorenzo NA,Olga Madridano NA,Ana Maestre NA,Pablo Javier Marchena NA,Mar Martín Del Pozo NA,Francisco Martín-Martos NA,Diego Martínez-Urbistondo NA,Carmen Mella NA,María Isabel Mercado NA,Arturo Muñoz-Blanco NA,José Antonio Nieto NA,Manuel Jesús Núñez-Fernández NA,Mónica Olid-Velilla NA,Sonia Otalora NA,Remedios Otero NA,Diana Paredes-Ruiz NA,Pedro Parra NA,Virginia Parra NA,José María Pedrajas NA,María Luisa Peris NA,José Antonio Porras NA,José Portillo NA,Pedro Ruiz-Artacho NA,Nuria Ruiz-Giménez NA,Justo Ruiz-Ruiz NA,Pablo Ruiz-Sada NA,Giorgina Salgueiro NA,Rosario Sánchez-Martínez NA,Juan Francisco Sánchez-Muñoz-Torrero NA,Teresa Sancho NA,Silvia Soler NA,Beatriz Suárez-Rodríguez NA,José María Suriñach NA,Carles Tolosa NA,María Isabel Torres NA,Andrea Torres-Sánchez NA,Fernando Uresandi NA,Beatriz Valero NA,Reina Valle NA,José Felipe Varona NA,Carmen Vázquez-Friol NA,Laura Vela NA,Jerónimo Ramón Vela NA,Aurora Villalobos NA,Paula Villares NA,Carles Zamora NA,Cihan Ay NA,Stephan Nopp NA,Ingrid Pabinger NA,Matthias Engelen NA,Thomas Vanassche NA,Hugo Hyung Bok Yoo NA,Jana Hirmerova NA,Sandrine Accassat NA,Nassim Ait Abdallah NA,Alessandra Bura-Riviere NA,Judith Catella NA,Francis Couturaud NA,Benjamin Crichi NA,Philippe Debourdeau NA,Olivier Espitia NA,Nicolas Falvo NA,Claire Grange NA,Hélène Helfer NA,Karine Lacut NA,Raphael Le Mao NA,Isabelle Mahé NA,Pierre Morange NA,Farès Moustafa NA,Geraldine Poenou NA,Gabrielle Sarlon-Bartoli NA,Pierre Suchon NA,Isabelle Quere NA,Reza Nikandish NA,Andrei Braester NA,Gili Kenet NA,Manuela Basaglia NA,Franca Bilora NA,Cristiano Bortoluzzi NA,Barbara Brandolin NA,Maurizio Ciammaichella NA,Chiara Corgna NA,A de Angelis NA,Egidio Imbalzano NA,Daniela Mastroiacovo NA,Simona Merla NA,Raffaele Pesavento NA,Fluvio Pomero NA,Carmine Siniscalchi NA,Antonella Tufano NA,Adriana Visonà NA,Ngoc Vo Hong NA,Beniamino Zalunardo NA,Dana Kigitovica NA,Elina Rusa NA,Andris Skride NA,Samuel Fonseca NA,Filipa Martins-Duarte NA,Jose Meireles NA
DOI: https://doi.org/10.1001/jamacardio.2022.1988
2022-08-01
Abstract:Importance: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in infrapopliteal veins without proximal extension or pulmonary embolism (PE). Objective: To determine the clinical characteristics, short-term, and 1-year outcomes in patients with IDDVT and to compare the outcomes in unadjusted and multivariable adjusted analyses with patients who had proximal DVT. Design, setting, and participants: This was a multicenter, international cohort study in participating sites of the Registro Informatizado Enfermedad Tromboembólica (RIETE) registry conducted from March 1, 2001, through February 28, 2021. Patients included in this study had IDDVT. Patients with proximal DVT were identified for comparison. Patients were excluded if they had a history of asymptomatic DVT, upper-extremity DVT, coexisting PE, or COVID-19 infection. Main outcomes and measures: Primary outcomes were 90-day and 1-year mortality, 1-year major bleeding, and 1-year venous thromboembolism (VTE) deterioration, which was defined as subsequent development of proximal DVT or PE. Results: A total of 33 897 patients were identified with isolated DVT (without concomitant PE); 5938 (17.5%) had IDDVT (mean [SD] age, 61 [17] years; 2975 male patients [50.1%]), and 27 959 (82.5%) had proximal DVT (mean [SD] age, 65 [18] years; 14 315 male patients [51.2%]). Compared with individuals with proximal DVT, those with IDDVT had a lower comorbidity burden but were more likely to have had recent surgery or to have received hormonal therapy. Patients with IDDVT had lower risk of 90-day mortality compared with those with proximal DVT (odds ratio [OR], 0.47; 95% CI, 0.40-0.55). Findings were similar in 1-year unadjusted analyses (hazard ratio [HR], 0.52; 95% CI, 0.46-0.59) and adjusted analyses (HR, 0.72; 95% CI, 0.64-0.82). Patients with IDDVT had a lower 1-year hazard of VTE deterioration (HR, 0.83; 95% CI, 0.69-0.99). In 1-year adjusted analyses of patients without an adverse event within the first 3 months, IDDVT was associated with lower risk of VTE deterioration (adjusted HR, 0.48; 95% CI, 0.24-0.97). By 1-year follow-up, symptoms or signs of postthrombotic syndrome were less common in patients with IDDVT (47.6% vs 60.5%). Conclusions and relevance: Results of this cohort study suggest that patients with IDDVT had a less ominous prognosis compared with patients with proximal DVT. Such differences were likely multifactorial, including the differences in demographics, risk factors, comorbidities, particularly for all-cause mortality, and a potential association of thrombus location with VTE deterioration and postthrombotic syndrome. Randomized clinical trials are needed to assess the optimal long-term management of IDDVT.